The American Culture of Clinical Oncology–School of American Pathologists (ASCO–CAP) recommendations have continued to evolve to Increase the accuracy and clinical utility of HER2 testing by furnishing specific algorithms15,16. In parallel with existing approaches, novel methods to quantify HER2 ranges or standardize strategies are being inves